Catalyst Wire Dossier Catalyst Wire Dossier

TNX-102 (sublingual)

cyclobenzaprine · Tonix Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNX-102 (sublingual), covering 2014-09-26 to 2014-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults [Phase 1]

See pricing